Literature DB >> 16922612

Standardizing chronic graft-versus-host disease.

Koen van Besien1.   

Abstract

Chronic graft-versus-host disease (cGVHD) is a common and difficult complication of allogeneic transplantation. Advances have been hindered by a lack of uniform criteria for diagnosis and staging and by a lack of high quality prospective studies. In six articles, consensus criteria are proposed for clinical and histological diagnoses and response assessments for cGVHD. Recommendations are also made for the study of biomarkers in cGVHD, for ancillary management and supportive care of patients with cGVHD and for the design of clinical studies. The recommendations and criteria proposed by the consensus group are likely to facilitate and profoundly alter the management and study of cGVHD.

Entities:  

Mesh:

Year:  2006        PMID: 16922612     DOI: 10.2217/14796694.2.4.459

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  1 in total

1.  Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.

Authors:  Koen van Besien; Rangesh Kunavakkam; Gaby Rondon; Marcos De Lima; Andrew Artz; Betul Oran; Sergio Giralt
Journal:  Biol Blood Marrow Transplant       Date:  2009-05       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.